FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065749 [Registered on: 16/04/2024] Trial Registered Prospectively
Last Modified On: 11/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Exploring effectiveness of intravenous Dexmedetomidine versus Tramadol in participants for post spinal anesthesia shivering management and comparison of the two drugs and understanding the primary outcome. 
Scientific Title of Study   Comparison of intravenous Dexmedetomidine vs Tramadol as anti-shivering agent following spinal anesthesia  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ruchita Sunil Raikar 
Designation  Junior resident in anesthesia department  
Affiliation  junior resident  
Address  Department of Anesthesiology, Eras medical college and hospital, Lucknow, Eras medical college and hospital, sarfarazganj, Lucknow, UP, Lucknow, Uttar Pradesh, 226003 India
Department of Anesthesiology, Eras medical college and hospital, Lucknow, Eras medical college and hospital, sarfarazganj, Lucknow, UP, Lucknow, Uttar Pradesh, 226003 India
Lucknow
UTTAR PRADESH
226003
India 
Phone  9619716371  
Fax    
Email  ruchitaraikar99@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prof Maj Sanjay Choubey  
Designation  Head of department of Anesthesiology  
Affiliation  Eras medical college and hospital 
Address  Eras Medical college and hospital, Sarfarzganj, Lucknow Uttar Pradesh 226003 India
Eras Medical college and hospital, Sarfarzganj, Lucknow Uttar Pradesh 226003 India
Lucknow
UTTAR PRADESH
226003
India 
Phone  8840155309  
Fax    
Email  sanjay.choubey@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prof Maj Sanjay Choubey  
Designation  Head of department of Anesthesiology  
Affiliation  Eras medical college and hospital 
Address  Eras Medical college and hospital, Sarfarzganj, Lucknow Uttar Pradesh 226003 India


UTTAR PRADESH
226003
India 
Phone  8840155309  
Fax    
Email  sanjay.choubey@yahoo.com  
 
Source of Monetary or Material Support  
Ruchita Raikar, Eras Lucknow Medical College and hospital, Lucknow, Uttar Pradesh -226003 
 
Primary Sponsor  
Name  Eras medical college and hospital 
Address  Sarfarzganj, Lucknow, Uttar Pradesh 226003 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ruchita Sunil Raikar  Operation Theatre  Eras medical college and hospital, Lucknow, Uttar Pradesh 226003 India
Lucknow
UTTAR PRADESH 
9619716371

ruchitaraikar99@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of Eras Lucknow Medical college and hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 4||Measurement and Monitoring, (2) ICD-10 Condition: 8||Other Procedures, (3) ICD-10 Condition: 3||Administration,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Comparison between Dexmedetomidine and Tramadol as anti-shivering agent post spinal anesthesia   Patients shall be visited on the evening prior to surgery They shall be re evaluated and pre anesthetic orders checked. Written and informed consent for anesthesia and for the study shall be obtained. Patients shall be kept nill per oral from midnight prior to surgery. On the day of surgery patients shall be assessed preoperatively, vitals shall be noted and intravenous access shall be secured. Patients shall be shifted to OT under constant reassurance.Standard monitors shall be attached and baseline parameters shall be recorded- Heart Rate (HR), Oxygen saturation (SpO2 ), Non-invasive blood pressure (NIBP) and ECG.Ringer Lactate infusion shall be started. No means of active warming will be used. Under all aseptic precautions spinal anaesthesia will be administered at the L3 – L4 intervertebral space, with the patient in sitting position. A volume of 3 ml of inj. bupivacaine 0.5% (heavy) shall be injected through a 27-gauge Quincke’s spinal needle. Patient shall be placed in supine position with a 15° head down tilt immediately after administration of the block.Oxygen (5L/min) shall be administered via face mask. Vitals shall be recorded every 5 minutes for first 30 minutes and after that, every 15 minutes till the end of the surgery. Temperature shall be recorded with thermometer probe every 5 minutes for 30 minutes and after that every 15 minutes till the end of the surgery.Appearance of shivering of moderate to severe shall be noted and the patient shall be randomized in one of the two groups by using the lottery method of randomization into (group A and group B) and the study drug shall be administered thereafter. Time taken to relieve shivering shall be recorded.Hypotension, defined as a decrease of mean arterial blood pressure(MAP) by more than 20% from baseline, shall be treated with incremental intravenous doses of phenylephrine 50 mcg and intravenous fluid as required.Bradycardia, defined as heart rate 50 beats per minute, shall be treated with intravenous Atropine 0.6 mg. After the end of surgery patients shall be shifted to the recovery room and observed. 
Comparator Agent  Dexmedetomidine, Tramadol  Comparision of intravenous Dexmedetomidine vs Tramadol as anti-shivering agent following spinal anesthesia 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  American society of anesthesiologists (ASA) physical status grade 1 and 2, patients who develop shivering post sub arachnoid block (spinal anesthesia) 
 
ExclusionCriteria 
Details  patient refusal, pregnancy, patients with known hypersensitivity to study drugs, ischemic heart disease, hepatic disease, hyperthyroidism, hypothyroidism, urinary tract infection, diabetes mellitus, known history of substance or alcohol abuse 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
the primary outcome of the study is to compare the effectiveness of intravenous dexmedetomidine versus tramadol as a anti shivering agent post spinal anesthesia and better agent that helps in subsiding the shivering faster with least amount of side effects.  time noted after onset of shivering and time taken to subside the shivering. vitals measured at every 5 minute interval till 30 minutes and every 15 minutes till end of surgery. 
 
Secondary Outcome  
Outcome  TimePoints 
side effects to be noted such as nausea, vomiting, bradycardia etc   at the end of study  
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   24/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   .Shivering is a common postanesthesia adverse event with an incidence of 40–70%.
Shivering is not only physically distressing for the patient, but can have various other detrimental effects. It may lead to pain, patient discomfort, impede monitoring techniques, increase intraocular and intracranial pressures, double or even triple oxygen consumption and carbon dioxide production, which might pose difficulties in patients with existing intrapulmonary shunts, fixed cardiac output or limited respiratory reserve.
Therefore by comparing the anti-shivering effect of Dexmedetomidine vs Tramadol post spinal anesthesia, a outcome can be achieved for a better anti-shivering agent amongst the two agents.
 
Close